Anticoagulant Reversal Drug Pulled From U.S. Market

(MedPage Today) — Andexanet alfa (Andexxa) will officially be taken off the U.S. market this month as an emergency reversal medication for contemporary blood thinners.
“The Biologics License Application for Andexxa has been withdrawn for commercial…